Evidence map›Paper›PMID 29884856›Full record

ArticleBone marrow transplantation2018

Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.

Ivana Moor, Vera U Bacher, Barbara Jeker, Behrouz Mansouri Taleghani, Beatrice U Mueller, Peter Keller, Daniel Betticher, Thomas Egger, Urban Novak, Thomas Pabst

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2020
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ivana MoorDepartment of Medical Oncology, Inselspital, University Hospital Bern, Bern, Switzerland.
Vera U BacherDepartment of Hematology, Inselspital, University Hospital Bern, Bern, Switzerland.
Barbara JekerDepartment of Medical Oncology, Inselspital, University Hospital Bern, Bern, Switzerland.
Behrouz Mansouri TaleghaniDepartment of Hematology, Inselspital, University Hospital Bern, Bern, Switzerland.
Beatrice U MuellerDepartment of Biomedical Research, University of Bern, Bern, Switzerland.
Peter KellerDepartment of Hematology, Regionalspital, Langenthal, Switzerland.
Daniel BetticherDepartment of Oncology, Kantonsspital, Fribourg, Switzerland.
Thomas EggerDepartment of Oncology, Kantonsspital, Solothurn, Switzerland. thomas.pabst@insel.ch.
Urban NovakDepartment of Medical Oncology, Inselspital, University Hospital Bern, Bern, Switzerland.
Thomas PabstDepartment of Medical Oncology, Inselspital, University Hospital Bern, Bern, Switzerland.
University Hospital of Bern · CHHFR Freiburg Kantonsspital · CHSolothurner Spitäler · CHUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedMultiple MyelomaNeoplasm, ResidualTransplantation, AutologousTransplantation Conditioning

Identifiers

PMID29884856
OpenAlexW2806277057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.